MedPath

Comparison of Three Methods of Hemoglobin Monitoring

Completed
Conditions
Blood Loss
Registration Number
NCT00792597
Lead Sponsor
University of California, San Francisco
Brief Summary

The purpose of this study is to compare the hemoglobin results obtained with 1) the HemoCue™, 2) the Masimo SpHb™, and 3) the UCSF Clinical Laboratory. The goal is to determine if these three values differ from each other during various levels of blood loss in the clinical care of patients for spine revision and hip revision surgery.

Detailed Description

See above

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Male or non-pregnant female 18 y/o or older
  • American Society of Anesthesiology Classification 1, 2 or 3
  • Scheduled to undergo spine or hip revision surgery
Read More
Exclusion Criteria
  • Pregnant or nursing
  • Patients who in the study investigators clinical judgement would not be suitable for research.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
See description belowA minimum of three differences recorded during surgery

Primary outcome is based on the difference between SpHb (Masimo SpHb™ continuous hemoglobin reading ) - tHb (laboratory hemoglobin determination).

Secondary Outcome Measures
NameTimeMethod
See description belowA minimum of three differences recorded during surgery

Secondary outcome is based on the difference between a HemoCue™ derived hemoglobin determination - laboratory hemoglobin determination.

Trial Locations

Locations (1)

University of California San Francisco

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath